The largest database of trusted experimental protocols

Ondansetron ond

Manufactured by Bio-Techne
Sourced in United Kingdom

Ondansetron (OND) is a chemical compound that is commonly used as a laboratory reagent. It is a selective 5-HT3 receptor antagonist, which means it binds to and blocks the 5-HT3 receptor, a type of serotonin receptor. Ondansetron is often used in research studies involving serotonin signaling and its effects on various biological processes.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using ondansetron ond

1

Intracerebral Drug Injections in DMH and DRt

Check if the same lab product or an alternative is used in the 5 most similar protocols
Solutions for intracerebral drug injections in the DMH and DRt were prepared with sterilized saline 0.9% (Unither, Amiens, France; pH 7.2) except for LIDO, which was acquired as a solution. Each injection had a volume of 0.5 μL and contained either 50 nmol of GLU (Merck, Darmstadt, Germany), LIDO 4% (OrionPharma, Espoo, Finland), 1 nmol of GAL (Tocris, Bristol, UK) or 0.3 nmol ondansetron (OND) (Tocris). In the results section, the behavioural and electrophysiological changes induced by a drug were considered at the time point of maximum effect of each drug: 1 min for GLU, 20 min for GAL and LIDO and 30 min for OND.
+ Open protocol
+ Expand
2

Serotonin Receptor Role in Masseter Muscle Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were prepared surgically as noted above for neural recording. Masseter muscle EMG activity was recorded from paired wire electrodes (0.12 mm diameter, 5 mm interpolar distance) implanted ~1 mm into the central portion of the masseter muscle ipsilateral to the TMJ cannula. The experimental design to test for 5HT3R involvement consisted of: 1) initial intra-TMJ injection of PBS, 2) intra-TMJ injection of ATP alone, 3) ondansetron (OND, 1 mM, 30 μl, pH = 7.4 in PBS, Tocris, Ellisville, MO) applied topically to the Vc/C1–2 surface 10 min prior to subsequent intra-TMJ injection of ATP, 4) intra-TMJ injection of ATP 30 min after OND. Intra-TMJ injections of ATP were separated by 20 min intervals. Masseter muscle EMG activity was sampled at 1000 Hz, amplified, filtered (300–3000 Hz), displayed and stored for analyses offline. EMG activity was assessed in sham rats (n = 12) and in FS-conditioned rats (n = 11).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!